D.E. Shaw & Co’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,934
Closed -$372K 4252
2019
Q3
$372K Sell
14,934
-22,654
-60% -$484K ﹤0.01% 3349
2019
Q2
$759K Sell
37,588
-33,017
-47% -$719K ﹤0.01% 2840
2019
Q1
$1.66M Sell
70,605
-13,342
-16% -$337K ﹤0.01% 2298
2018
Q4
$1.71M Sell
83,947
-41,362
-33% -$1.13M ﹤0.01% 2282
2018
Q3
$5.4M Buy
125,309
+12,767
+11% +$551K 0.01% 1539
2018
Q2
$4.91M Buy
112,542
+4,576
+4% +$200K 0.01% 1549
2018
Q1
$5.21M Buy
107,966
+74,934
+227% +$3.6M 0.01% 1381
2017
Q4
$1.68M Sell
33,032
-386
-1% -$21.1K ﹤0.01% 2265
2017
Q3
$1.92M Buy
33,418
+28,555
+587% +$1.42M ﹤0.01% 2063
2017
Q2
$251K Buy
+4,863
New +$251K ﹤0.01% 3098
2016
Q1
Sell
-11,857
Closed -$421K 3892
2015
Q4
$421K Buy
+11,857
New +$406K ﹤0.01% 3180
2014
Q3
Sell
-14,494
Closed -$401K 4486
2014
Q2
$397K Sell
14,494
-8,721
-38% -$224K ﹤0.01% 3690
2014
Q1
$531K Sell
23,215
-8,533
-27% -$166K ﹤0.01% 3559
2013
Q4
$559K Sell
31,748
-4,875
-13% -$84.1K ﹤0.01% 3652
2013
Q3
$629K Buy
36,623
+19,124
+109% +$305K ﹤0.01% 3407
2013
Q2
$255K Buy
+17,499
New +$252K ﹤0.01% 3659

Other funds holding LDL

D.E. Shaw & Co's LDL Position: Q4 2019 in Review

D.E. Shaw & Co sold out of Lydall, Inc. (LDL) in Q4 2019, closing a stake of 14,934 shares — an estimated $372K sold.

D.E. Shaw & Co first reported a position in LDL in Q2 2013 and held it in 16 quarters. The position peaked at $5.4M in Q3 2018. 125 funds tracked by Wall St. Rank hold LDL as of Q4 2019.

  • D.E. Shaw & Co reported no remaining Lydall, Inc. position as of Q4 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 14,934 Lydall, Inc. shares in Q4 2019, an estimated $372K.
  • D.E. Shaw & Co first reported a position in Lydall, Inc. in Q2 2013 and held it in 16 quarters.
  • D.E. Shaw & Co's Lydall, Inc. position peaked at $5.4M in Q3 2018.
  • 125 funds tracked by Wall St. Rank held Lydall, Inc. as of Q4 2019.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.